Skip to content

Application of type I interferon in clinical testing

Application of type I interferon in clinical testing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104247
Enrollment
Unknown
Registered
2025-06-13
Start date
2025-06-19
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Tract Infection (RTI)

Interventions

Trial group:NA

Sponsors

Liuzhou people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Research participants or their legal guardians voluntarily agreed to participate in the study and provided signed informed consent; 2. Patients aged >28 days and <80 years, regardless of gender; 3. Patients presented with clinically evident upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI); 4. Completed tNGS testing.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Patients who did not sign the informed consent form; 3. Patients with severe comorbidities affecting major organ systems, including but not limited to: cardiac, cerebral, respiratory, circulatory, endocrine, immune, or hematopoietic systems.

Design outcomes

Primary

MeasureTime frame
Levels of Type I IFNs;

Countries

China

Contacts

Public ContactYing Wu

Liuzhou people's hospital

aqiwuying@hotmail.com+86 772 266 2052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026